Accelerating drug development
Here, Dave Elder explores how a ‘quick-approval, quick-withdrawal from the market’ approach is used to accelerate drug development.
Source: europeanpharmaceuticalreview.com
Stay updated with breaking news from Clinical Limitations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Here, Dave Elder explores how a ‘quick-approval, quick-withdrawal from the market’ approach is used to accelerate drug development.